Clinical trials sponsored by Fox Chase Cancer Center

Phase breakdown

Conditions studied

Recruiting trials led by Fox Chase Cancer Center

• Adaptive Radiation Boost for Rectal Cancer
  NCT07221058 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
  NCT07219303 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
  NCT06984562 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer
  NCT05800587 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy
  NCT07167446 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma
  NCT05498792 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many trials is Fox Chase Cancer Center recruiting for?

Fox Chase Cancer Center is the lead sponsor of 6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.